Menu

Under Pressure

The causes and consequences of physical forces in the tumor microenvironment

Apr 1, 2016
Lance L. Munn and Rakesh K. Jain

© N.R.FULLER, SAYO-ART LLC

Tumors create and experience a variety of forces. Pockets of excessive cell growth lead to increased mechanical stresses on and deformation of the extracellular matrix (ECM), which is made up of fibroblasts, collagen, and other fibers. Greater numbers of infiltrating stromal and immune cells can similarly stretch the matrix, as can hydrogel components such as hyaluronan molecules, which absorb water and swell. The deformed matrix, in turn, may facilitate the metastatic escape of cancer cells and cause blood vessels within the tumor to collapse, inhibiting the delivery of nutrients, removal of waste, and entry of tumor-targeted drugs. Reduced blood flow can also result in hypoxia, which may lead to immunosuppression, inflammation, and metastasis, as well as lowered efficacy of chemo-, radio-, and immunotherapies. Compressive stresses may also induce cells to become more invasive, perhaps by inducing the expression of oncogenes.

In addition to these solid forces, fluid pressure exerted by the circulatory system can force interstitial fluid to flow from the tumor. Escape of plasma from blood vessels produces shear stresses that can affect cancer cells, blood vessels, myofibroblasts, and immune cells, as well as promote tumor progression by recruiting blood vessels into the tumor and guiding the migration of cancer cells out of the tumor.

Read the full story.

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics
Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics
Ready-to-use immunoassay kit increases analytical output and productivity in bioprocess workflows. Kit developed as part of licensing and supply agreement with Cygnus Technologies
IDT launches ultra-high performance CRISPR Cas12a enzyme
IDT launches ultra-high performance CRISPR Cas12a enzyme
IDT’s new CRISPR Cas12a (Cpf1) Ultra enzyme can target new sites within the genome and with greater efficiency
Implen Launches New NanoPhotometer N120: The High Throughput Champion!
Implen Launches New NanoPhotometer N120: The High Throughput Champion!
Implen GmbH is excited to announce the release of the NanoPhotometer® N120, an absorbance based UV/VIS Multi Channel Spectrophotometer.
StemExpress Announces Release of New Frozen Leukopak® to Advance Research
StemExpress Announces Release of New Frozen Leukopak® to Advance Research
To continue to provide new products and services to further advance medical research around the world, today, StemExpress announced the release of their Frozen Leukopak®.